Gilead And Roche Resolve Tamiflu Licensing Dispute

Increased antiviral demand in the face of seasonal flu and the threat of pandemic avian flu leads the firms to settle arbitration over a manufacturing and commercialization agreement.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet